Search Videos and More
News
Adstiladrin (Nadofaragene Firadenovec-vncg): The First Intravesical Gene Therapy for Bladder Cancer Now Available at Fox Chase
Eligible patients will now have access to the first FDA-approved intravesical gene therapy for non-muscle invasive bladder cancer (NMIBC) at Fox Chase Cancer Center.
News
Meet the Navigators to Complex, Coordinated, Compassionate Genitourinary Cancer Care
A prostate, kidney, or bladder cancer diagnosis can turn someone’s world upside down. If this weren’t enough, now the patient has an additional burden of coordinating medical appointments, scheduling tests, and gathering biopsy results from other hospitals.
News
Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life.
Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.
News
New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment
Could NanoKnife be the future of prostate cancer care?
News
A Salvage Treatment Jennifer Was Inspired to Salvage.
A Life-Saving Idea for Bladder Cancer Patients.
News
Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment
Bladder removal is life-altering. This study examines when and why some patients may not need it.
News
A $1.4 Million Grant Looks at Prostate Cancer Through a ‘Neighborhood Lens.’
Where a man is born, lives and works can influence his prostate cancer diagnosis, treatment, and survival. But which factors matter most? And what role do they all play together in how he responds to cancer treatment?
News
Dr. Laura Bukavina on the Front Lines of Research and War
Fighting for life everywhere she goes.
Video
What is the Same and What Has Changed with the Artificial Urinary Sphincter?
The artificial urinary sphincter is an implantable device designed to treat incontinence in prostate cancer survivors. The device has existed for 50 years, and in that time, best practices around its use have undergone several paradigm shifts.
News
Fox Chase Urology Just Took a Big Leap Forward
A new benign urology team adds gravitas to a renowned cancer department.
News
Fox Chase Researchers Examine Racial Differences in Treatment and Outcomes of First-Line Therapies for Kidney Cancer
Digging into the "why" of racial disparity in kidney cancer outcomes.
News
Transperineal Biopsy
For some men who need a biopsy to test for prostate cancer, Fox Chase Cancer Center now offers an alternative approach that is safer, with significantly lower risks of infection, and potentially higher rate of tumor detection. This new procedure, called transperineal biopsy, uses an external entry point in the perineum area, instead of the more traditional transrectal (through the rectum wall) approach. A rectal ultrasound probe helps the physician guide the biopsy instrument to reach more areas in the prostate, including the anterior region that is more difficult to access using the transrectal method.